DE602007013306D1 - Mutilinderivate und ihre verwendung als arzneimittel - Google Patents

Mutilinderivate und ihre verwendung als arzneimittel

Info

Publication number
DE602007013306D1
DE602007013306D1 DE602007013306T DE602007013306T DE602007013306D1 DE 602007013306 D1 DE602007013306 D1 DE 602007013306D1 DE 602007013306 T DE602007013306 T DE 602007013306T DE 602007013306 T DE602007013306 T DE 602007013306T DE 602007013306 D1 DE602007013306 D1 DE 602007013306D1
Authority
DE
Germany
Prior art keywords
mutilins
phenylsulfanyl
acetyl
alkyl
mutiline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007013306T
Other languages
English (en)
Inventor
Klaus Thirring
Gerd Ascher
Susanne Paukner
Werner Heilmayer
Rodger Novak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nabriva Therapeutics AG
Original Assignee
Nabriva Therapeutics AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nabriva Therapeutics AG filed Critical Nabriva Therapeutics AG
Publication of DE602007013306D1 publication Critical patent/DE602007013306D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/22—Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
    • C07C2603/80—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
    • C07C2603/82—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE602007013306T 2006-01-16 2007-01-11 Mutilinderivate und ihre verwendung als arzneimittel Active DE602007013306D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06000827A EP1808431A1 (de) 2006-01-16 2006-01-16 Mutilin Derivate und ihre Verwendung als Arzneimittel
PCT/AT2007/000009 WO2007079515A1 (en) 2006-01-16 2007-01-11 Mutilin derivatives and their use as pharmaceutical

Publications (1)

Publication Number Publication Date
DE602007013306D1 true DE602007013306D1 (de) 2011-05-05

Family

ID=36127922

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007013306T Active DE602007013306D1 (de) 2006-01-16 2007-01-11 Mutilinderivate und ihre verwendung als arzneimittel

Country Status (18)

Country Link
US (1) US7816389B2 (de)
EP (3) EP1808431A1 (de)
JP (2) JP5489467B2 (de)
KR (1) KR101434683B1 (de)
CN (1) CN101379027B (de)
AT (1) ATE502917T1 (de)
BR (1) BRPI0707117B8 (de)
CA (1) CA2635950C (de)
DE (1) DE602007013306D1 (de)
DK (1) DK1838665T3 (de)
EA (1) EA019579B1 (de)
ES (1) ES2363806T3 (de)
HK (1) HK1125624A1 (de)
IL (1) IL192756A (de)
NO (1) NO341298B1 (de)
PL (1) PL1838665T3 (de)
TW (1) TWI428316B (de)
WO (1) WO2007079515A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1808431A1 (de) 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin Derivate und ihre Verwendung als Arzneimittel
EP2014640A1 (de) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin-Derivate
JP6715772B2 (ja) * 2014-01-22 2020-07-01 ナブリヴァ セラピュティクス ゲーエムベーハー １２−ｅｐｉ−プロイロムチリン
CN104803911B (zh) * 2014-01-23 2018-01-05 中国科学院上海药物研究所 一类截短侧耳素化合物、其药物组合物、合成方法与用途
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
CN115197169B (zh) * 2018-11-02 2023-07-11 华南农业大学 一种以2-氨基苯巯醇为连接基团截短侧耳素衍生物制备方法和用途
EP4135681A1 (de) * 2020-04-17 2023-02-22 Nabriva Therapeutics GMBH Neue therapeutische verwendung von pleuromutilinen
CN111689914B (zh) * 2020-06-18 2021-09-24 华南农业大学 一种具有1,2,4-三唑席夫碱的截短侧耳素衍生物及制备与应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979423A (en) * 1969-07-25 1976-09-07 Biochemie Gesellschaft M.B.H. 14-Desoxy-14-tosyloxyacetoxy-mutilin
CH560180A5 (en) * 1971-10-05 1975-03-27 Sandoz Ag Pleuromutilin derivs - with antibacterial activity
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
ZA80175B (en) * 1979-01-12 1981-08-26 Sandoz Ltd New pleuromutilin derivatives, their production and use
DE2966635D1 (en) * 1979-01-12 1984-03-08 Sandoz Ag New pleuromutilin derivatives, their production and pharmaceutical compositions containing them
JP3054875B2 (ja) * 1995-02-13 2000-06-19 株式会社小松製作所 プラズマトーチ
GB9817029D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
WO2000027790A1 (en) * 1998-11-11 2000-05-18 Smithkline Beecham P.L.C. Mutilin compounds
GB9918037D0 (en) * 1999-07-30 1999-09-29 Biochemie Gmbh Organic compounds
TWI260220B (en) * 1999-11-22 2006-08-21 Novartis Ag A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
PE20020676A1 (es) * 2000-09-13 2002-08-27 Biochemie Gmbh Compuestos de mutilina como antibacterianos
GB0207495D0 (en) * 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
GB0209262D0 (en) * 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
CN100355729C (zh) * 2002-07-24 2007-12-19 桑多斯股份公司 截短侧耳素
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
JP5373393B2 (ja) 2005-06-27 2013-12-18 ナブリヴァ セラピュティクス アクチエンゲゼルシャフト ヒドロキシアミノ基またはアシルオキシアミノシクロアルキル基を含むプレウロムチリン誘導体
GB0513058D0 (en) 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
GB0515995D0 (en) * 2005-08-03 2005-09-07 Sandoz Ag Organic compounds
EP1808431A1 (de) 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Mutilin Derivate und ihre Verwendung als Arzneimittel
EP1972618A1 (de) * 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin-Derivate zur Behandlung von Krankheiten vermittelt durch Mikroben

Also Published As

Publication number Publication date
IL192756A0 (en) 2009-02-11
EP1838665A1 (de) 2007-10-03
EP2266955B1 (de) 2017-07-26
US7816389B2 (en) 2010-10-19
CN101379027A (zh) 2009-03-04
EP2266955A1 (de) 2010-12-29
EA019579B1 (ru) 2014-04-30
DK1838665T3 (da) 2011-07-11
BRPI0707117B8 (pt) 2021-05-25
CN101379027B (zh) 2014-09-24
JP2013136583A (ja) 2013-07-11
HK1125624A1 (en) 2009-08-14
US20080287442A1 (en) 2008-11-20
CA2635950A1 (en) 2007-07-19
KR101434683B1 (ko) 2014-08-26
CA2635950C (en) 2016-08-30
BRPI0707117B1 (pt) 2020-08-04
KR20080104273A (ko) 2008-12-02
BRPI0707117A2 (pt) 2011-04-19
JP5489467B2 (ja) 2014-05-14
TWI428316B (zh) 2014-03-01
NO20083409L (no) 2008-09-18
PL1838665T3 (pl) 2011-09-30
JP2009531278A (ja) 2009-09-03
ATE502917T1 (de) 2011-04-15
EP1838665B1 (de) 2011-03-23
ES2363806T3 (es) 2011-08-17
EP1808431A1 (de) 2007-07-18
NO341298B1 (no) 2017-10-02
EA200870171A1 (ru) 2009-02-27
IL192756A (en) 2015-10-29
TW200736205A (en) 2007-10-01
WO2007079515A1 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
DE602007013306D1 (de) Mutilinderivate und ihre verwendung als arzneimittel
DE602006013878D1 (de) Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
ECSP099044A (es) Compuestos de pirimido fusionados
ATE488232T1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
MY152503A (en) 4-phenyl-pyrane-3, 5-diones, 4-phenyl-thiopyrane-3, 5-diones and cyclohexanetriones as novel herbicides
NO20081003L (no) 2-Aminopyrimidinderivater som modulatorer av histamin-H4-reseptoraktivitet
GB0508318D0 (en) Organic compounds
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
ATE486079T1 (de) Azatricyclische verbindungen und deren verwendung
GB0508314D0 (en) Organic compounds
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
ATE472549T1 (de) Octahydropyrroloä3,4-cüpyrrolderivate und ihre verwendung als antivirale mittel
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
MX2010001093A (es) Herbicidas novedosos.
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
SG151306A1 (en) Novel benzothiazoles and the use thereof as medicaments
CO6251376A2 (es) Triazolilpiridina cetonas herbicidas
DE602006002887D1 (de) Tricyclische azolderivate, ihre herstellung und ihre verwendung als pharmazeutische mittel
ATE435865T1 (de) Als pde5-inhibitoren verwendete pyrazoloä4,3- düpyrimidin-5-ylderivate
DE602006014530D1 (de) Pharmazeutisch aktive diazepane
PA8646301A1 (es) Inhibidores de la adenilato ciclasa soluble
ATE355265T1 (de) Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren
DE602004024538D1 (de) Sulphonamid benzoxazinonderivate. ihre herstellung und verwendung als medikamente